Jiangsu Cowin Biotech Co (SHSE:688426) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688426 Jiangsu Cowin Biotech Co Ltd SHSE:688426
63 GF Score
Price ¥15.44
GF Value ¥29.26
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Jiangsu Cowin Biotech Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Jiangsu Cowin Biotech Co Valuation Rank Related Terms

SHSE:688426
63GF Score
Jiangsu Cowin Biotech Co Ltd SHSE:688426
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Jiangsu Cowin Biotech Co (SHSE:688426) Overvalued in 2026?

Based on GuruFocus' analysis, Jiangsu Cowin Biotech Co stock appears to be undervalued. The current stock price of ¥15.44 is trading 47.2% below its estimated GF Value™ of ¥29.26. GuruFocus considers Jiangsu Cowin Biotech Co to be Possible Value Trap.

Key valuation signals for SHSE:688426:

  • Valuation Rank:
  • GF Value™: ¥29.26 vs. price of ¥15.44 (47.2% below fair value)
  • GF Score™: 63/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688426 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jiangsu Cowin Biotech Co Business Description

Address No. 1 Yaocheng Avenue, 4th Floor, TQB Building, Jiangsu Province, Taizhou, CHN, 225300
Jiangsu Cowin Biotech Co Ltd is a national high-tech enterprise with independent intellectual property rights based in the field of life sciences. It provides innovative biological products and services to in vitro diagnostic users. The product line mainly includes molecular diagnostic raw materials enzymes, nucleic acid collection and protection agents, nucleic acid extraction kits, molecular diagnostic detection reagents and others.
63GF Score

Get the complete analysis for SHSE:688426

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.44
Price
¥29.26
GF Value